Cell-associated nonesterified fatty acid levels and their alteration during lipolysis in the isolated mouse adipose cell.
A rapid and flexible method has been developed for measuring cell-associated, probably intracellular, nonesterified fatty acids (CAFA) in isolated mouse adipose cells. A variety of lipolytic agents as well as various concentrations of epinephrine elevate CAFA levels in rough proportion to their stimulation of glycerol and fatty acid release. Insulin reduces epinephrine-elevated CAFA levels. A detailed, quantitative study of the relationship among lipolytic activity, CAFA levels, and the extracellular molar ratio of fatty acids to albumin has been carried out. Epinephrine-elevated CAFA levels rise linearly with, while epinephrine-stimulated lipolytic activity is independent of, fatty acid to albumin ratios below 2-3. As the ratio increases from 3 to 5, CAFA levels continue to increase, whereas lipolytic activity decreases. Above ratios of 5, fatty acid release almost completely ceases; CAFA levels increase dramatically with residual glycerol release. A temperature-dependent efflux of epinephrine-elevated CAFA can be elicited through blockade of stimulated lipolysis with propranolol, but only in the presence of extracellular fatty acid to albumin ratios below 3. These observations suggest that during stimulated lipolysis, a fatty acid gradient exists between the cell and extracellular serum albumin and that CAFA represent the intracellular component of this gradient. In addition, these observations support the concept that intracellular fatty acids play a role in the feedback regulation of adipose cell function as extracellular fatty acids accumulate during the lipolytic response.
D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000494:pharmacology; D004822:Epididymis; D004837:Epinephrine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000032:analysis / Q000378:metabolism*; D005246:Feedback; D005947:Glucose; D005976:Glutaral; D005990:Glycerol / Q000032:analysis; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D008053:Lipid Mobilization / Q000187:drug effects*; D008297:Male; D051379:Mice; D009829:Oleic Acids / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011773:Pyruvates; D012709:Serum Albumin
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D009829:Oleic Acids; D011773:Pyruvates; D012709:Serum Albumin; D000324:Adrenocorticotropic Hormone; D011433:Propranolol; D000242:Cyclic AMP; D005947:Glucose; D005990:Glycerol; D005976:Glutaral; D004837:Epinephrine